|
⚲
|
| Keyboard |
| Rajesh Devraj | |
|---|---|
| Firm | |
| Address | c/o Indalo Therapeutics, Inc 4320 Forest Park Avenue, Suite 304 St Louis, MO 63108 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Indalo Therapeutics Inc | 021-291882 | Director | 9.0 M of 26.0 M |
||
| Antegrin Therapeutics Inc | 021-248659 | Director | 0.6 M of 0.6 M |
||
| Antegrin Therapeutics Inc | 021-248662 | Director | 0.1 M of 0.6 M |
||
| Euclises Pharmaceuticals Inc | 021-248588 | Director | 1.2 M of 2.7 M |
||
| Euclises Pharmaceuticals Inc | 021-209852 | Executive Officer | 1.9 M of 1.9 M |
||
| Tansna Therapeutics Inc | 021-203528 | Director | of 0.8 M |
||